Madfes Dermatology & Aesthetics Group Spring 2023 letter.
Osaka, Japan, here they come! The dynamic mother & daughter duo, Mallory & Diane, are teaming up with the American Academy of Dermatology for their fifth year of Skin Cancer, Take a Hike!™....
Introducing Ellacor® – the first and only FDA-approved fractional micro-coring device that removes excess skin to improve skin laxity! A small gauge needling device is used to create tiny punches in...
Common Medical Skin Conditions
Pre & Post-Treatment Instructions
What's NewSofwave™ Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental and Neck Facial Areas
The U.S. Food and Drug Administration (FDA) approves clearance for lifting the eyebrow and lifting lax submental tissue (beneath the chin) and neck tissue; which can also affect the appearance of lax tissue in the submental neck regions, for subjects aged 22 or older. In addition, the Sofwave system featuring the Company’s proprietary SUPERB TM technology is also cleared by the U.S. FDA for a non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles. – from Sofwave™ News Press Release
- immediate results can be seen as soon as 1 week (ongoing improvements in 3 months after treatment)
- minimal downtime (resume daily activities post treatment!)
- most patients only need one treatment (but may benefit from additional treatments)